Powerful PCSK9 inhibitors were supposed to revolutionize care for cardiac patients. But insurers and other payers balked at sky-high prices.
from Health https://ift.tt/2Qj9S6C
October 01, 2018
Rose
Health, Health - The New York Times
No comments
Related Posts:
For Millennials Making Their Way, a Detour: To CaregivingHere is a concern that baby boomers might not have thought of: Their children could be taking care of them while still in their 20s or 30s. from Health https://ift.tt/2OmbC0C … Read More
It’s Not Just Poor White People Driving a Decline in Life ExpectancyA new study shows that death rates increased for middle-aged people of all racial and ethnic groups. from Health https://ift.tt/2OTmgeC … Read More
Eating After You Exercise May Provide Added Fat-Burning BenefitsCyclists who had pedaled on an empty stomach incinerated about twice as much fat as those who had consumed a shake first. from Health https://ift.tt/34rtehf … Read More
C.D.C. Reports More E. Coli Illnesses Linked to Romaine LettuceThe agency said the outbreak had affected 19 states and resulted in 39 people being hospitalized. from Health https://ift.tt/34qjKTr … Read More
Measles Cases Continue to Rise Around the WorldNearly a quarter of a million people in the Democratic Republic of Congo are thought to have been infected by measles in 2019 alone, the World Health Organization said. from Health https://ift.tt/37HVNJA … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment